Pura Vida Investments as of March 31, 2018
Portfolio Holdings for Pura Vida Investments
Pura Vida Investments holds 56 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 9.7 | $16M | 300k | 54.47 | |
| Select Sector Spdr Tr Sbi Healthcare Put Option (XLV) | 7.7 | $13M | 160k | 81.40 | |
| Alexion Pharmaceuticals | 4.9 | $8.4M | 75k | 111.47 | |
| Sientra | 4.6 | $7.7M | 798k | 9.66 | |
| Incyte Corporation (INCY) | 4.2 | $7.1M | 85k | 83.33 | |
| ICU Medical, Incorporated (ICUI) | 4.2 | $7.1M | 28k | 252.39 | |
| Globus Med Cl A (GMED) | 4.0 | $6.7M | 135k | 49.82 | |
| Livanova SHS (LIVN) | 3.8 | $6.4M | 72k | 88.50 | |
| Bristol Myers Squibb Call Option (BMY) | 3.7 | $6.3M | 100k | 63.25 | |
| CIGNA Corporation Call Option | 3.5 | $5.9M | 35k | 167.74 | |
| Baxter International (BAX) | 2.9 | $4.9M | 75k | 65.04 | |
| Invacare Corporation | 2.8 | $4.8M | 277k | 17.40 | |
| Intersect Ent | 2.6 | $4.3M | 110k | 39.30 | |
| Rigel Pharmaceuticals Com New | 2.5 | $4.2M | 1.2M | 3.54 | |
| Abbott Laboratories (ABT) | 2.1 | $3.6M | 61k | 59.92 | |
| athenahealth | 2.1 | $3.6M | 25k | 143.04 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $3.5M | 44k | 81.08 | |
| Edwards Lifesciences (EW) | 2.1 | $3.5M | 25k | 139.52 | |
| Medtronic SHS (MDT) | 2.0 | $3.4M | 43k | 80.21 | |
| Allergan SHS | 2.0 | $3.4M | 20k | 168.30 | |
| Dex (DXCM) | 1.6 | $2.8M | 37k | 74.15 | |
| Viewray (VRAYQ) | 1.6 | $2.7M | 422k | 6.43 | |
| Qiagen Nv Shs New | 1.4 | $2.4M | 75k | 32.31 | |
| Boston Scientific Corporation (BSX) | 1.4 | $2.4M | 88k | 27.33 | |
| United Therapeutics Corporation (UTHR) | 1.3 | $2.2M | 20k | 112.35 | |
| Zogenix Com New | 1.2 | $2.0M | 50k | 40.05 | |
| Arena Pharmaceuticals Com New | 1.2 | $2.0M | 50k | 39.50 | |
| Accuray Incorporated Call Option (ARAY) | 1.1 | $1.9M | 389k | 5.00 | |
| Natus Medical | 1.1 | $1.9M | 58k | 33.65 | |
| Amgen Call Option (AMGN) | 1.0 | $1.7M | 10k | 170.50 | |
| Spectrum Pharmaceuticals Call Option | 1.0 | $1.6M | 100k | 16.09 | |
| Amicus Therapeutics (FOLD) | 0.9 | $1.5M | 100k | 15.04 | |
| Cardiovascular Systems | 0.9 | $1.5M | 67k | 21.93 | |
| Nuvectra | 0.9 | $1.5M | 113k | 13.02 | |
| Biohaven Pharmaceutical Holding | 0.8 | $1.3M | 52k | 25.76 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $1.3M | 72k | 18.75 | |
| Kala Pharmaceuticals | 0.7 | $1.3M | 80k | 15.83 | |
| Glaukos (GKOS) | 0.7 | $1.2M | 40k | 30.82 | |
| Conformis | 0.6 | $1.1M | 731k | 1.45 | |
| Evolus (EOLS) | 0.5 | $926k | 103k | 9.03 | |
| Exelixis (EXEL) | 0.5 | $886k | 40k | 22.15 | |
| Aimmune Therapeutics | 0.5 | $821k | 26k | 31.84 | |
| Array BioPharma Call Option | 0.5 | $816k | 50k | 16.32 | |
| Acer Therapeutics | 0.5 | $805k | 42k | 19.26 | |
| Viking Therapeutics (VKTX) | 0.5 | $764k | 175k | 4.37 | |
| Clearside Biomedical (CLSD) | 0.4 | $725k | 68k | 10.72 | |
| Tg Therapeutics (TGTX) | 0.4 | $710k | 50k | 14.20 | |
| Steadymed SHS | 0.4 | $699k | 215k | 3.25 | |
| Otonomy | 0.4 | $640k | 153k | 4.20 | |
| Fate Therapeutics (FATE) | 0.3 | $582k | 60k | 9.77 | |
| Gw Pharmaceuticals Ads | 0.3 | $563k | 5.0k | 112.60 | |
| Coherus Biosciences Call Option (CHRS) | 0.3 | $553k | 50k | 11.06 | |
| Jounce Therapeutics | 0.3 | $485k | 22k | 22.35 | |
| Motus Gi Hldgs Incorporated | 0.3 | $448k | 100k | 4.48 | |
| Vascular Biogenics Put Option | 0.1 | $230k | 100k | 2.30 | |
| Foamix Pharmaceuticals SHS | 0.1 | $124k | 24k | 5.15 |
